Therapeutic Asset Ratings

862 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Cephalexin Inflammatory Disease	Mayo Clinic	P4	BB (65)
Cephalexin MRSA	Mayo Clinic	P4	BB (65)
Cephalexin MSSA Colonization	Mayo Clinic	P4	BB (65)
Cephalexin Tobacco Use	Mayo Clinic	P4	BB (65)
FLORTAUCIPIR Apraxia of Speech	Mayo Clinic	P4	BB (65)
FLORTAUCIPIR Non-fluent Aphasia	Mayo Clinic	P4	BB (65)
FLORTAUCIPIR Primary Progressive Non-fluent Aphasia	Mayo Clinic	P4	BB (65)
FLORTAUCIPIR Vascular Dementia	Mayo Clinic	P4	BB (65)
FLUDEOXYGLUCOSE Vascular Dementia	Mayo Clinic	P4	BB (65)
IOFLUPANE Parkinsonism	Mayo Clinic	P4	BB (65)
LIDOCAINE Advanced Knee Osteoarthritis	Mayo Clinic	P4	BB (65)
Meta-Iodobenzylguanidine Lewy Body Disease	Mayo Clinic	P4	BB (65)
Meta-Iodobenzylguanidine Parkinsonism	Mayo Clinic	P4	BB (65)
Meta-Iodobenzylguanidine REM Sleep Behavior Disorder	Mayo Clinic	P4	BB (65)
Phentermine GLP - 1	Mayo Clinic	P4	BB (65)
Phentermine Schizo Affective Disorder	Mayo Clinic	P4	BB (65)
PITTSBURGH COMPOUND B UNLABELLED FTD	Mayo Clinic	P4	BB (65)
PITTSBURGH COMPOUND B UNLABELLED Vascular Dementia	Mayo Clinic	P4	BB (65)
Semaglutide Cardiomyopathy	Mayo Clinic	P4	BB (65)
Semaglutide Schizo Affective Disorder	Mayo Clinic	P4	BB (65)
Suvorexant Delirium	Mayo Clinic	P4	BB (65)
Tirzepatide Menopause Hot Flashes	Mayo Clinic	P4	BB (65)
Topamax GLP - 1	Mayo Clinic	P4	BB (65)
Wellbutrin Bipolar I Disorder	Mayo Clinic	P4	BB (65)
Wellbutrin GLP - 1	Mayo Clinic	P4	BB (65)

Showing 76 to 100 of 862 assets